Arwen Podesta, MD, defines what prescription digital therapeutics (PDTs) are, describes how they differ from nonprescription digital health tools, and details the FDA review process for PDTs.
Can you define what prescription digital therapeutics (PDTs) are and describe how they differ from nonprescription digital health tools?
What is the FDA review process for PDTs, and how is it different from the review process for prescription drugs and medical devices? How does FDA authorization of a PDT factor into clinical decision-making about a treatment?
How Magellan’s Behavior Health Program Saved up to $4,300 PMPY
November 7th 2023Using an AI platform, Magellan Health was able to better support providers in prescribing behavioral health medications and addressing medication problems, which reduced pharmacy costs and increased adherence.
Read More